HEADER TRANSFERASE/TRANSFERASE INHIBITOR 22-MAY-14 4PMS TITLE THE STRUCTURE OF TRKA KINASE BOUND TO THE INHIBITOR 4-NAPHTHALEN-1-YL- TITLE 2 1-[(5-PHENYL-1,2,4-OXADIAZOL-3-YL)METHYL]-1H-PYRROLO[3,2-C]PYRIDINE- TITLE 3 2-CARBOXYLIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 501-787); COMPND 5 SYNONYM: NEUROTROPHIC TYROSINE KINASE RECEPTOR TYPE 1,TRK1- COMPND 6 TRANSFORMING TYROSINE KINASE PROTEIN,TROPOMYOSIN-RELATED KINASE A, COMPND 7 TYROSINE KINASE RECEPTOR,TYROSINE KINASE RECEPTOR A,TRK-A,GP140TRK, COMPND 8 P140-TRKA; COMPND 9 EC: 2.7.10.1; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NTRK1, MTC, TRK, TRKA; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.P.SU REVDAT 4 27-DEC-23 4PMS 1 SOURCE JRNL REMARK REVDAT 3 25-FEB-15 4PMS 1 REMARK REVDAT 2 01-OCT-14 4PMS 1 JRNL REVDAT 1 18-JUN-14 4PMS 0 JRNL AUTH S.J.STACHEL,J.M.SANDERS,D.A.HENZE,M.T.RUDD,H.P.SU,Y.LI, JRNL AUTH 2 K.K.NANDA,M.S.EGBERTSON,P.J.MANLEY,K.L.JONES,E.J.BRNARDIC, JRNL AUTH 3 A.GREEN,J.A.GROBLER,B.HANNEY,M.LEITL,M.T.LAI,V.MUNSHI, JRNL AUTH 4 D.MURPHY,K.RICKERT,D.RILEY,A.KRASOWSKA-ZOLADEK,C.DALEY, JRNL AUTH 5 P.ZUCK,S.A.KANE,M.T.BILODEAU JRNL TITL MAXIMIZING DIVERSITY FROM A KINASE SCREEN: IDENTIFICATION OF JRNL TITL 2 NOVEL AND SELECTIVE PAN-TRK INHIBITORS FOR CHRONIC PAIN. JRNL REF J.MED.CHEM. V. 57 5800 2014 JRNL REFN ISSN 0022-2623 JRNL PMID 24914455 JRNL DOI 10.1021/JM5006429 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 65.63 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 9016 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.168 REMARK 3 R VALUE (WORKING SET) : 0.164 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.240 REMARK 3 FREE R VALUE TEST SET COUNT : 472 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.72 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2531 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1845 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2392 REMARK 3 BIN R VALUE (WORKING SET) : 0.1790 REMARK 3 BIN FREE R VALUE : 0.2870 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.49 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 139 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2247 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 47 REMARK 3 SOLVENT ATOMS : 26 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 51.05 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.57490 REMARK 3 B22 (A**2) : -6.57490 REMARK 3 B33 (A**2) : 13.14980 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.273 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 2.651 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.328 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.922 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.849 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2357 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3191 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 796 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 48 ; 8.000 ; HARMONIC REMARK 3 GENERAL PLANES : 392 ; 8.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2357 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 284 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2683 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.13 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.11 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.91 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4PMS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-MAY-14. REMARK 100 THE DEPOSITION ID IS D_1000201715. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-APR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS 0.2.8 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9042 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 65.630 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.12900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.70 REMARK 200 R MERGE FOR SHELL (I) : 0.45200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BIS-TRIS, 2.3M AMMONIUMACETATE, REMARK 280 PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 64 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z+1/3 REMARK 290 6555 X-Y,X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.39667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 74.79333 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 37.39667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 74.79333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 901 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 534 REMARK 465 GLU A 535 REMARK 465 GLN A 536 REMARK 465 ALA A 549 REMARK 465 SER A 550 REMARK 465 GLU A 551 REMARK 465 GLY A 684 REMARK 465 GLY A 685 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 537 CG OD1 OD2 REMARK 470 LYS A 538 CG CD CE NZ REMARK 470 GLN A 555 CG CD OE1 NE2 REMARK 470 ARG A 559 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 583 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 682 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 686 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 514 146.01 -174.60 REMARK 500 ASN A 531 84.09 63.90 REMARK 500 LEU A 532 49.75 -147.07 REMARK 500 ALA A 618 64.99 34.37 REMARK 500 ARG A 649 -25.42 88.04 REMARK 500 ASN A 655 30.09 -97.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 31X A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 803 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 804 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 805 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4PMM RELATED DB: PDB REMARK 900 RELATED ID: 4PMP RELATED DB: PDB REMARK 900 RELATED ID: 4PMT RELATED DB: PDB DBREF 4PMS A 501 787 UNP P04629 NTRK1_HUMAN 501 787 SEQADV 4PMS HIS A 788 UNP P04629 EXPRESSION TAG SEQADV 4PMS HIS A 789 UNP P04629 EXPRESSION TAG SEQADV 4PMS HIS A 790 UNP P04629 EXPRESSION TAG SEQADV 4PMS HIS A 791 UNP P04629 EXPRESSION TAG SEQRES 1 A 291 CYS VAL HIS HIS ILE LYS ARG ARG ASP ILE VAL LEU LYS SEQRES 2 A 291 TRP GLU LEU GLY GLU GLY ALA PHE GLY LYS VAL PHE LEU SEQRES 3 A 291 ALA GLU CYS HIS ASN LEU LEU PRO GLU GLN ASP LYS MET SEQRES 4 A 291 LEU VAL ALA VAL LYS ALA LEU LYS GLU ALA SER GLU SER SEQRES 5 A 291 ALA ARG GLN ASP PHE GLN ARG GLU ALA GLU LEU LEU THR SEQRES 6 A 291 MET LEU GLN HIS GLN HIS ILE VAL ARG PHE PHE GLY VAL SEQRES 7 A 291 CYS THR GLU GLY ARG PRO LEU LEU MET VAL PHE GLU TYR SEQRES 8 A 291 MET ARG HIS GLY ASP LEU ASN ARG PHE LEU ARG SER HIS SEQRES 9 A 291 GLY PRO ASP ALA LYS LEU LEU ALA GLY GLY GLU ASP VAL SEQRES 10 A 291 ALA PRO GLY PRO LEU GLY LEU GLY GLN LEU LEU ALA VAL SEQRES 11 A 291 ALA SER GLN VAL ALA ALA GLY MET VAL TYR LEU ALA GLY SEQRES 12 A 291 LEU HIS PHE VAL HIS ARG ASP LEU ALA THR ARG ASN CYS SEQRES 13 A 291 LEU VAL GLY GLN GLY LEU VAL VAL LYS ILE GLY ASP PHE SEQRES 14 A 291 GLY MET SER ARG ASP ILE TYR SER THR ASP TYR TYR ARG SEQRES 15 A 291 VAL GLY GLY ARG THR MET LEU PRO ILE ARG TRP MET PRO SEQRES 16 A 291 PRO GLU SER ILE LEU TYR ARG LYS PHE THR THR GLU SER SEQRES 17 A 291 ASP VAL TRP SER PHE GLY VAL VAL LEU TRP GLU ILE PHE SEQRES 18 A 291 THR TYR GLY LYS GLN PRO TRP TYR GLN LEU SER ASN THR SEQRES 19 A 291 GLU ALA ILE ASP CYS ILE THR GLN GLY ARG GLU LEU GLU SEQRES 20 A 291 ARG PRO ARG ALA CYS PRO PRO GLU VAL TYR ALA ILE MET SEQRES 21 A 291 ARG GLY CYS TRP GLN ARG GLU PRO GLN GLN ARG HIS SER SEQRES 22 A 291 ILE LYS ASP VAL HIS ALA ARG LEU GLN ALA LEU ALA GLN SEQRES 23 A 291 ALA HIS HIS HIS HIS HET 31X A 801 34 HET CL A 802 1 HET ACT A 803 4 HET ACT A 804 4 HET ACT A 805 4 HETNAM 31X 4-(NAPHTHALEN-1-YL)-1-[(5-PHENYL-1,2,4-OXADIAZOL-3-YL) HETNAM 2 31X METHYL]-1H-PYRROLO[3,2-C]PYRIDINE-2-CARBOXYLIC ACID HETNAM CL CHLORIDE ION HETNAM ACT ACETATE ION FORMUL 2 31X C27 H18 N4 O3 FORMUL 3 CL CL 1- FORMUL 4 ACT 3(C2 H3 O2 1-) FORMUL 7 HOH *26(H2 O) HELIX 1 AA1 ALA A 553 LEU A 567 1 15 HELIX 2 AA2 ASP A 596 HIS A 604 1 9 HELIX 3 AA3 ASP A 607 ALA A 612 1 6 HELIX 4 AA4 GLY A 623 LEU A 644 1 22 HELIX 5 AA5 ALA A 652 ARG A 654 5 3 HELIX 6 AA6 GLY A 670 TYR A 676 1 7 HELIX 7 AA7 SER A 677 TYR A 680 5 4 HELIX 8 AA8 PRO A 690 MET A 694 5 5 HELIX 9 AA9 PRO A 695 ARG A 702 1 8 HELIX 10 AB1 THR A 705 THR A 722 1 18 HELIX 11 AB2 SER A 732 GLY A 743 1 12 HELIX 12 AB3 PRO A 753 TRP A 764 1 12 HELIX 13 AB4 GLU A 767 ARG A 771 5 5 HELIX 14 AB5 SER A 773 ALA A 787 1 15 SHEET 1 AA1 5 ILE A 510 GLU A 518 0 SHEET 2 AA1 5 GLY A 522 CYS A 529 -1 O LEU A 526 N TRP A 514 SHEET 3 AA1 5 MET A 539 LEU A 546 -1 O ALA A 545 N LYS A 523 SHEET 4 AA1 5 LEU A 585 GLU A 590 -1 O PHE A 589 N ALA A 542 SHEET 5 AA1 5 PHE A 575 CYS A 579 -1 N PHE A 576 O VAL A 588 SHEET 1 AA2 2 CYS A 656 GLY A 659 0 SHEET 2 AA2 2 VAL A 663 ILE A 666 -1 O LYS A 665 N LEU A 657 SHEET 1 AA3 2 TYR A 681 ARG A 682 0 SHEET 2 AA3 2 MET A 688 LEU A 689 -1 O LEU A 689 N TYR A 681 CISPEP 1 ARG A 583 PRO A 584 0 3.63 SITE 1 AC1 10 VAL A 524 ALA A 542 LYS A 544 VAL A 573 SITE 2 AC1 10 PHE A 589 LEU A 657 ASP A 668 PHE A 669 SITE 3 AC1 10 GLY A 670 MET A 671 SITE 1 AC2 2 PRO A 754 TYR A 757 SITE 1 AC3 4 GLY A 625 ARG A 649 ARG A 702 HOH A 903 SITE 1 AC4 4 ARG A 602 LYS A 725 GLN A 726 TYR A 729 SITE 1 AC5 6 TRP A 718 THR A 722 LYS A 725 TYR A 729 SITE 2 AC5 6 PRO A 749 HOH A 917 CRYST1 75.780 75.780 112.190 90.00 90.00 120.00 P 64 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013196 0.007619 0.000000 0.00000 SCALE2 0.000000 0.015238 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008913 0.00000